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1 Introduction
The problem of identifying genes that are diﬀerentially expressed across varying biological condi-
tions based on microarray data has been a problem of much recent interest (Cui & Churchill 2003).
It is now possible to simultaneously measure thousands of related variables or “features” in a
variety of biological studies. Many of these high-dimensional biological studies are aimed at identi-
fying features showing a biological signal of interest, usually through the application of large-scale
signiﬁcance testing. For example, signiﬁcance analyses are often performed in DNA microarray,
comparative genomic hybridization, genome-wide comparative genomics, protein array, mass spec-
trometry, and genome-wide association studies (Cui & Churchill 2003, Sebastiani et al. 2003, Wang
et al. 2005). In many of these applications, the true biological signals of interest across the features
are expected to be related. This motivates investigating approaches to large-scale testing that take
advantage of widespread structure in high-dimensional data.
We propose a new approach for performing simultaneous signiﬁcance tests on many features in
a high-dimensional study. This approach is based on the “optimal discovery procedure” (ODP),
recently developed from a theoretical perspective (Storey 2005). The ODP was shown to be optimal
in that it maximizes the expected number of true positives for each ﬁxed level of expected false
positives; this is also directly related to optimality in terms of the popular false discovery rate
(FDR). Here, we introduce approaches to estimating the ODP in practice, and we propose a
fully developed method for identifying diﬀerentially expressed genes in comparative microarray
experiments.
In a microarray study, there is very often pervasive asymmetry in diﬀerential expression that
is not due to chance. Indeed, it would seem unlikely that overall diﬀerential expression would be
symmetric, unless the experiment was designed to achieve this behavior. Asymmetric diﬀerential
expression is an example of the existence of an underlying structure present among thousands of
features in a high-dimensional biological study. Due to the pathway structure of gene expression
regulation, the expression measurements of genes are related at an even ﬁner scale, which yields
further structure in observed diﬀerential expression.
A procedure for identifying diﬀerentially expressed genes should take advantage of this struc-
ture, the same holding true for other high-dimensional biological studies where much structure in
signal is present. The ODP approach does exactly this, utilizing the relevant information from
the entire data set in testing each gene for diﬀerential expression. The commonly used statistics
in high-dimensional studies, such as the t-statistic, F-statistic, or the chi-square statistic, were
originally designed for performing a single signiﬁcance test. Whereas these statistics are formed
using information from only one feature at a time, the ODP takes advantage of the structure in
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high-dimensional data.
There are two steps implicitly required for performing large-scale signiﬁcance testing in high-
dimensional biological studies: (1) order the features from those showing the most signal of interest
to those showing the least; (2) assign a signiﬁcance level to each feature, allowing one to draw a
signiﬁcance cut-oﬀ somewhere along this ordering. As an example, the signiﬁcance analysis of a
microarray study involves ranking the genes from most diﬀerentially expressed to least (the ﬁrst
step), and then drawing a signiﬁcance cut-oﬀ based on, say, an estimate of the FDR (the second
step). This paper is focused on the ﬁrst step, namely estimating an optimal ordering of the features.
The second step, which is not developed in this paper, has been addressed with new signiﬁcance
measures for high-dimensional studies, such as the FDR (Storey & Tibshirani 2003).
Estimating the ODP in practice requires the development of a number of ideas beyond those
considered in the more theoretical setting of Storey (2005), which we illustrate through the microar-
ray application. For example, whereas a t-statistic automatically cancels out ancillary information
in testing for diﬀerential expression, certain approaches to estimating the ODP do not. Therefore,
steps must be taken so that such ancillary information has no eﬀect on the signiﬁcance results.
Here, we introduce a general set of methodology that overcomes a number of these challenges.
We demonstrate the proposed ODP approach for identifying diﬀerentially expressed genes on a
well-known breast cancer expression study (Hedenfalk et al. 2001), as well as on simulated data. We
compare the results to those from ﬁve leading diﬀerential expression methods (Tusher et al. 2001,
Kerr et al. 2000, Dudoit et al. 2002, Cui et al. 2005, Efron et al. 2001, Lonnstedt & Speed 2002). Our
method consistently shows substantial improvements in performance over these existing methods.
For example, in testing for diﬀerential expression between BRCA1 and BRCA2 mutation-positive
tumors, the ODP approach provides increases from 72% to 185% in the number of genes called
signiﬁcant at a 3% FDR. A comparison between the methods over a range of FDRs is shown in
Figure 2 and Table 1.
2 The Optimal Discovery Procedure
2.1 Optimality goals
The typical goal when identifying diﬀerentially expressed genes is to ﬁnd as many true positives as
possible, without incurring too many false positives (Storey & Tibshirani 2003). Sometimes genes
found to be signiﬁcantly diﬀerentially expressed are subsequently studied on a case-by-case basis in
order to determine their role in the diﬀering biological conditions. It is also now possible to discover
functional relationships among signiﬁcant genes based on a number of ontological databases, making
this an attractive and more frequently used follow-up investigation technique (Zhong et al. 2004).
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Because of these goals in microarray experiments and a variety of other high-dimensional bio-
logical applications, the FDR has emerged as a popular criterion for assessing signiﬁcance in high-
dimensional biological studies (Storey & Tibshirani 2003). The FDR is deﬁned to be the proportion
of false positives among all features called signiﬁcant (Soric 1989, Benjamini & Hochberg 1995).
For example, if 100 genes are called signiﬁcant at the 5% FDR level, then one expects 5 out of
these 100 to be false positives. When investigating the functional relationships of a set of signiﬁcant
genes, the FDR has the nice interpretation that it represents the level of “noise” present in the
genes used to draw conclusions about the functional relationships.
Instead of working directly with FDRs, the ODP is based on two more fundamental quantities:
the expected number of true positives (ETP) and the expected number of false positives (EFP).
Speciﬁcally, the ODP is deﬁned as the testing procedure that maximizes the ETP for each ﬁxed
EFP level. Since FDR optimality can be written in terms of maximizing the ETP for each ﬁxed
EFP level (Storey 2005), the ODP also provides optimality properties for FDR. A consequence of
this optimality is that the rate of “missed discoveries” is minimized for each FDR level. In fact,
the optimality properties of the ODP translate to a variety of settings, including misclassiﬁcation
rates (Storey 2005). This optimality can also be formulated as a multiple test extension of this
Neyman-Pearson optimality (Storey 2005).
2.2 ODP statistic
The ODP is very much related to one of the fundamental ideas behind individual signiﬁcance
tests: the Neyman-Pearson lemma. Given a single set of observed data, the optimal single testing
procedure is based on the statistic
SNP(data) =
probability of the data under the alternative distribution
probability the of data under the null distribution
.
The null hypothesis is then rejected if the statistic SNP(data) exceeds some cut-oﬀ chosen to satisfy
an acceptable Type I error rate. (Here, the larger the statistic is, the more signiﬁcant the test
is.) This Neyman-Pearson procedure is optimal because it is “most powerful,” meaning that for
each ﬁxed Type I error rate, there does not exist another rule that exceeds this one in power. The
optimality follows intuitively from the fact that the strength of the alternative versus the null is
assessed by comparing their exact likelihoods.
The ODP statistic may be written similarly to the NP statistic. However, instead of considering
the data evaluated at its own alternative and null probability density functions, the ODP considers
the data for a single feature evaluated at all true probability density functions. Let “datai” be the
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data for the ith feature being tested. The ODP statistic for feature i is calculated as
SODP(datai) =
sum of probability of datai under each true alternative distribution
sum of probability of datai under each true null distribution
. (1)
For a ﬁxed cut-oﬀ chosen to attain an acceptable EFP level (or FDR level), each null hypothesis is
rejected if its ODP statistic SODP(datai) exceeds the cut-oﬀ. Note that “datai” has been evaluated at
all true probability densities, thereby using the relevant information from the entire set of features.
For each feature’s data, evidence is added across the true alternatives and compared to that across
the true nulls in forming the ratio.
Figure 1 gives a graphical representation of the ODP statistic, and its relative behavior to the
NP statistic. It can be seen there that the diﬀerence between the two is that the ODP borrows
strength across all of the tests, as opposed to using information from only one test at a time.
This point is explored in depth in Storey (2005). In the Supplementary Material, we provide a toy
example showing how microarray data contains information shared across genes that can be utilized
by the ODP. The NP procedure and ODP are theoretical procedures that must be estimated in
practice. As it turns out, the estimated ODP may show favorable operating characteristics over
estimated NP procedures when testing many hypotheses, as we demonstrate in this article.
2.3 Mathematical formulation
To make the deﬁnition of the ODP statistic more precise, suppose that m signiﬁcance tests are per-
formed on observed data sets x1,x2, . . . ,xm, where each signiﬁcance test consists of n observations
so that each xi = (xi1, xi2, . . . , xin). For the microarray application that we consider, xij is the
relative expression level of gene i on array j. In this case, there are m genes tested for diﬀerential
expression, based on n microarrays.
Assume that signiﬁcance test i has null probability density function fi and alternative density
gi; without loss of generality suppose that the null hypothesis is true for tests i = 1, 2, . . . ,m0 and
the alternative is true for i = m0 + 1, . . . ,m. In this notation, the ODP statistic of equation (1) is
written as:
SODP(x) =
gm0+1(x) + gm0+2(x) + · · ·+ gm(x)
f1(x) + f2(x) + · · ·+ fm0(x)
. (2)
Null hypothesis i is rejected if and only if SODP(xi) ≥ λ, where λ is chosen to satisfy an acceptable
EFP or FDR level. In practice the exact forms of the fi and gi are unknown, as well as which of
the tests have a true null hypothesis. Therefore, this statistic not only requires one to know the
distributions associated with each test, but also whether the null or alternative is true for each test.
This seemingly nonsensical requirement turns out to be tractable when estimating the ODP.
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Figure 1: Plots comparing the NP testing approach to the ODP testing approach through a simple example. (a)
NP approach. The null (grey) and alternative (black) probability density functions of a single test. For observed
data x and y, the statistics are calculated by taking the ratio of the alternative to the null densities at each respective
point. In this NP approach, the test with data y is more signiﬁcant than the test with data x. (b) ODP approach.
The common null density (grey) for true null tests and the alternative densities (black) for several true alternative
tests. For observed data x and y, the statistics are calculated by taking the ratio of the sum of alternative densities
to the null density evaluated at each respective point. In this ODP approach, the test with data x is now more
signiﬁcant than the test with data y, because multiple alternative densities have similar positive means even though
each one is smaller than the single alternative density with negative mean.6
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However, it requires that we use a diﬀerent but equivalent form of the statistic. The following
equivalently deﬁnes the ODP, as shown by Storey (2005):
SODP(x) =
f1(x) + f2(x) + · · ·+ fm0(x) + gm0+1(x) + gm0+2(x) + · · ·+ gm(x)
f1(x) + f2(x) + · · ·+ fm0(x)
, (3)
which equals 1 + eq. (2). Since eq. (3) = 1 + eq. (2), these produce the exact same testing
procedure [where a threshold of λ applied to the statistic deﬁned in equation (2) is equivalent to a
threshold of 1 + λ applied to the statistic deﬁned in equation (3)]. Because of this equivalence and
the tractability of estimating the statistic in equation (3), we employ and estimate this statistic for
the remainder of the article.
3 Proposed Approach for Estimating the ODP
Since the true ODP requires information not known in practice, the procedure must be estimated;
here, we propose some general methodology for doing so. The goal when estimating the ODP is to
be able to reproduce the same ranking of features as the true ODP. Note that it is not necessary
to reproduce the ODP statistics exactly, but rather their relative ranking. In order to estimate the
ODP statistic of equation (3), one must estimate the true probability density function for each test
and also address the fact that only the true null tests are represented in the denominator of the
statistic. The ﬁrst challenge is straightforward to address: we use the observed data for each test
in order to estimate its true probability function. This is clearly justiﬁed by the fact that the data
are generated from that true density function. The second challenge can be addressed in several
ways, some of which we propose below.
3.1 A canonical plug-in estimate
A parametric approach can be taken to estimate the ODP, motivated by the generalized likelihood
ratio test for single signiﬁcance tests. Recall that fi and gi will both be deﬁned by a set of
parameters (e.g., the mean and variance of a Normal distribution). For each test i = 1, . . . ,m, let
f̂i be the maximum likelihood estimate
1 of fi based on data xi under the constraints of the null
hypothesis, and let ĝi be the unconstrained maximum likelihood estimate. In single hypothesis
testing, the Neyman-Pearson procedure for test i is based on gi(xi)/fi(xi), and it can be estimated
by the generalized likelihood ratio statistic ĝi(xi)/f̂i(xi) (Lehmann 1986). Our proposed approach
builds on this strategy.
1Technically speaking, bfi is the version of fi deﬁned by the unknown parameters’ maximum likelihood estimates
under the constraints of the null hypothesis.
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For true null hypotheses i = 1, . . . ,m0, the maximum likelihood parameters deﬁning f̂i and ĝi
are both consistent estimates of the actual values of fi as the number of observations n grows to
inﬁnity. Likewise, ĝi is composed of consistent parameter estimates of gi for false null hypotheses
i = m0 +1, . . . ,m. Therefore, ĝ1 + · · ·+ ĝm can be used to estimate the numerator of equation (3),
where it is now unnecessary to be able to distinguish between true and false null hypotheses. This
motivates the following “canonical estimate” of the ODP statistic:
ŜODP(x) =
ĝ1(x) + · · ·+ ĝm0(x) + ĝm0+1(x) + · · ·+ ĝm(x)
f̂1(x) + · · ·+ f̂m0(x)
. (4)
We use the term “canonical” because the above is a direct plug-in estimate of the ODP thresholding
function, where all unknown parameters are consistently estimated.
Consistency in the number of observations n for each test is not necessarily the best property
to be concerned about in this setting, since it will usually be the case that n  m; nevertheless,
many of the commonly used statistics (t, F, chi-square) can be motivated from this perspective,
while also displaying good small sample properites. Other well behaved estimates of the fi and gi
could certainly be employed if they show favorable operating characteristics.
3.2 Common null distribution estimate
In general, it will not be possible to employ the canonical estimate because it requires one to be
able to identify the densities of the true null hypotheses. If a common null distribution f exists and
is known, then one does not need to know which of the null hypotheses are true. The canonical
ODP estimate can then be simpliﬁed to
ŜODP(x) =
∑m
i=1 ĝi(x)
f(x)
. (5)
Note that sometimes it is possible to transform the data so that the null distribution becomes
known and common among all tests (e.g., by replacing the data with a pivotal statistic). However,
this may remove much of the information in the data, making this approach less desirable. If there
is no common and known null distribution, then the following more generally applicable estimate
is proposed.
3.3 Generally applicable estimate
One general approach is to approximate the canonical plug-in estimate by estimating which null
densities should be included in the denominator of the statistic. Let ŵi = 1 if f̂i is to be included
8
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in the denominator, and ŵi = 0 otherwise. The estimate of the ODP statistic is then
ŜODP(x) =
∑m
i=1 ĝi(x)∑m
i=1 ŵif̂i(x)
. (6)
More generally, the ŵi can be thought of as weights serving as estimates of the true status of each
hypothesis. We have deﬁned them as equaling zero or one, but they could take on a continuum of
values as well.
We propose and implement a simple approach to forming the ŵi for the microarray application
below, although many diﬀerent approaches would be possible. This simple approach is based on
ranking the tests by using a univariate statistic (e.g., a t-statistic). For all statistics exceeding some
cut-oﬀ (i.e., those appearing to be signiﬁcant and not likely to be true nulls), we set ŵi = 0; for
those not exceeding the cut-oﬀ, we set ŵi = 1. The cut-oﬀ is formed so that the proportion falling
below and receiving ŵi = 1 is equal to an estimate of the proportion of true null hypotheses, based
on the method in Storey (2002) and Storey & Tibshirani (2003).
Note that if the tests are consistent, then we expect the true alternative tests to rise above
the cut-oﬀ with probability one. The proportion of true null tests can be estimated unbiasedly in
this case (Storey 2002), providing a reasonable method for extracting the true null densities to be
employed in the denominator of the statistic. Our particular version of this procedure, based on
a Kruskal-Wallis test statistic and the estimate of the proportion of true nulls by Storey (2002)
and Storey & Tibshirani (2003), performs nearly as well as the canonical estimate according to our
simulations.
3.4 Nuisance parameter invariance
In addition to estimating the ODP well, it is also necessary to consider the eﬀect of ancillary
information on the procedure. Speciﬁcally, it is desirable to obtain a “nusiance parameter invari-
ance” property. Suppose that all signiﬁcance tests have equivalently deﬁned null and alternative
hypotheses and their probability density functions all come from the same family. If the null dis-
tributions fi are not equal then this is due to diﬀering nuisance parameters. However, simply
changing the nuisance parameters of the true null hypotheses can produce substantial (and some-
times undesirable) alterations in the ODP (Supplementary Material). A strong way to enforce
nuisance parameter invariance is to require all fi to be equal. Alternatively, one may require that∑m
i=1 fi/m =
∑m0
i=1 fi/m0 so that on average there is no relationship between the status of the
hypotheses and the null distributions. See Supplementary Material for a more detailed discussion
on this important property.
In practice, it is sometimes possible to formulate the signiﬁcance tests or transform the data
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so that
∑m
i=1 fi/m ≈
∑m0
i=1 fi/m0. When this nuisance parameter invariance property is met,∑m
i=1 f̂i/m may serve as an estimate of
∑m0
i=1 fi/m0, yielding the following estimate of the ODP
thresholding rule:
ŜODP(x) =
∑m
i=1 ĝi(x)∑m
i=1 f̂i(x)
, (7)
where the unknown constant m0/m can be omitted. However, it may also be diﬃcult to estimate
the fi for true alternative tests since their data are in fact generated from the alternative density
gi. In other words, f̂i may be a poor estimate of fi for i > m0, making the denominator of equation
(7) poorly behaved.
4 ODP for Identifying Diﬀerentially Expressed Genes
For the microarray application, we found the implementation based on our general estimate of
equation (6) to perform the best. This implementation requires (i) fi and gi to be deﬁned, (ii)
estimates f̂i and ĝi to be derived, (iii) an estimate of which f̂i to employ in the denominator to
be derived, and (iv) justiﬁcation that the nuisance parameter invariance condition
∑m
i=1 fi/m =∑m0
i=1 fi/m0 is approximately met.
Some notation is necessary to describe the implementation. We assume expression is measured
on m genes from n arrays, where the n arrays come from one of two distinct groups. (The method-
ology easily extends to there being one, two, or more groups – details are given below.) Let µi1
be the mean of gene i in group 1, and µi2 be the mean of gene i in group 2, i = 1, . . . ,m. When
gene i is not diﬀerentially expressed, these means are equal and we denote them by their common
mean µi0. We denote xij to be the expression observation for gene i in array j, for i = 1, . . . ,m
and j = 1, . . . , n. As before, we represent the data for a single gene by xi = (xi1, xi2, . . . , xin).
Also, let xi1 be the subset of data from group 1 and xi2 the subset of data from group 2. For
example, with seven arrays in group 1 and eight in group 2, we write xi1 = (xi1, xi2, . . . , xi7) and
xi2 = (xi8, xi9, . . . , xi15).
4.1 Probability density functions
The model we use to estimate the ODP is that xij comes from a Normal distribution with mean
µi1 or µi2 (depending on the group that array j belongs to) and variance σ
2
i . Note that this is
only an assumption insofar as claims are made about the accuracy of the estimated ODP with
respect to the true ODP. We do not make any distributional assumptions when assessing the level
of statistical signiﬁcance for each feature. We assume that the expression measurements xij are on
the log-scale or whatever scale makes the use of the Normal densities most reasonable.
10
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Under this assumption, the likelihood of a set of data can be written using the Normal prob-
ability density function φ. For example, the likelihood of data x with mean µ and variance σ2 is
written as
φ(x;µ, σ2) =
1
(2πσ2)n/2
exp
{
−
∑n
j=1(xj − µ)
2
2σ2
}
.
In the notation used to deﬁne the general ODP estimates, we therefore deﬁne
fi(x) = φ(x;µi0, σ
2
i ) and gi(x) = φ(x1;µi1, σ
2
i )φ(x2;µi2, σ
2
i ).
For hypothesis i, the likelihood of data x is fi(x) under the null and gi(x) under the alternative.
4.2 Estimates of the densities
Ignoring nuisance parameter invariance issues, it is straightforward to deﬁne estimates of these
densities. Let (µ̂i0, σ̂
2
i0) be the maximum likelihood estimates under the constraints of the null
hypothesis, and (µ̂i1, µ̂i2, σ̂
2
iA) be the unconstrained maximum likelihood estimates. These are
simply the sample means and variances under the assumptions of the null and alternative hypothe-
ses, respectively (Supplementary Material). The above densities can then simply be estimated by
f̂i(·) = φ(·; µ̂i0, σ̂
2
i0) and ĝi(·) = φ(·; µ̂i1, σ̂
2
iA)φ(·; µ̂i2, σ̂
2
iA). Below, we modify these density deﬁni-
tions and estimates to approximately achieve nuisance parameter invariance.
4.3 Extracting true null densities for the denominator
We also estimate which null densities should appear in the denominator of the statistic. The
ultimate goal is to recover the canonical estimate (equation (6)), where only f̂i corresponding to
true nulls are present in the denominator. We take the approach outlined in that Section 3.3,
summarized in the following algorithm.
1. Perform a Kruskal-Wallis test for diﬀerential expression on each gene, and rank the genes
from most diﬀerentially expressed to least according to this test.
2. Using the p-values from these tests, estimate the number of diﬀerentially expressed genes m̂0
according to the methodology in Storey (2002) and Storey & Tibshirani (2003).
3. Set ŵi = 1 for the genes falling in the bottom m̂0 of the ranking; set ŵi = 0 otherwise.
A rank-based test is used mainly because it is computationally eﬃcient. Furthermore, if a t-
statistic or F-statistic were used, then this runs the risk of preferentially selecting genes with small
variances by chance, a phenomenon previously noted about such statistics (Tusher et al. 2001). It
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should be stressed that this is one of many approaches one could take to estimating which null
densities to include in the denominator. We anticipate that better strategies will be found in the
future. However, the procedure proposed here does in fact show improvements over setting all
ŵi = 1. Furthermore, at this stage it is not necessarily so important to identify individual null
genes well, but rather to identify a subset so that
∑m
i=1 ŵif̂i approximates
∑m0
i=1 fi well.
4.4 Nuisance parameter invariance
According to our notation, the null hypothesis for gene i is that µi1 = µi2 and the alternative is that
µi1 = µi2. This can be re-written as µi1 − µi2 = 0 versus µi1 − µi2 = 0. Without loss of generality,
the common mean when the null hypothesis is true can be deﬁned as µi0 = (n1µi1 + n2µi2)/n,
where n1 and n2 are the number of arrays in groups 1 and 2, respectively. The data for gene i can
then be equivalently parameterized by (µi0, µi1 − µi2, σ
2
i ) rather than (µi1, µi2, σ
2
i ). It is clear that
the parameters µi0 and σ
2
i are not of interest in the hypothesis test; these are the so-called nuisance
parameters.
Recall that the goal is to approximately achieve the equality
∑m
i=1 fi/m =
∑m0
i=1 fi/m0. If (i)
the distribution of the σ2i is unrelated to the distribution of the µi1 − µi2 and (ii) each µi0 = 0,
then we can approximately achieve the nuisance parameter invariance condition (Supplementary
Material). Standard methods make it straightforward to transform the data so that there is no
apparent relationship between the σ2i and the µi1 − µi2 (Rocke & Durbin 2003), so this condition
can often be fulﬁlled in practice. Ideally, we would force µi0 = 0 by subtracting the true µi0 from
each xij for j = 1, . . . , n. However, µi0 are unknown, so these must be estimated. Therefore, we
set µ̂i0 =
∑n
j=1 xij/n and deﬁne x
∗
ij = xij − µ̂i0, thereby centering each gene around zero.
With the data transformed in this manner, it follows that µ∗i0 = 0, µ
∗
i1 = µi1 − µi0 and µ
∗
i2 =
µi2 − µi0, with estimates µ̂
∗
i1 = µ̂i1 − µ̂i0 and µ̂
∗
i2 = µ̂i2 − µ̂i0. The variances σ
2
i do not change, so
these can be estimated as before by taking the sample variances under the assumptions of the null
and alternative hypotheses to get σ̂2i0 and σ̂
2
iA, respectively.
4.5 Estimated ODP thresholding function
The ODP for identifying diﬀerentially expressed genes between two groups can then be estimated
by forming the following statistic for each gene i = 1, 2, . . . ,m:
ŜODP(xi) =
∑m
g=1 φ(x
∗
i1; µ̂
∗
g1, σ̂
2
gA)φ(x
∗
i2; µ̂
∗
g2, σ̂
2
gA)∑m
g=1 ŵiφ(x
∗
i ; 0, σ̂
2
g0)
.
12
Hosted by The Berkeley Electronic Press
Note that the centered data for gene i, x∗i is evaluated at the estimated likelihood functions for all
genes. Therefore, if gene g has a similar signal to gene i, then its likelihood under the alternative
will contribute substantially to the estimated ODP statistic of gene i. Also, the variance of a gene
is taken into account in its contribution to the statistic, where the smaller the variance, the more
its likelihood is allowed to contribute to gene i’s statistic. The formula of the statistic also makes it
clear why it is useful to use the gene-centered data x∗i . Strength is borrowed across genes that have
a similar structure in the signal, even if they have diﬀerent baseline levels of expression (which is
not of interest for detecting diﬀerential gene expression).
This method is easily extended to a general K-sample analysis, where K diﬀerent biological
groups are compared for diﬀerential expression. For example, in a 3-sample analysis the goal is to
identify genes whose mean expression is diﬀerent in at least one of the three groups. The estimated
ODP statistic for a K-sample signiﬁcance test of diﬀerential expression is a simple extension of the
above 2-sample statistic:
ŜODP(xi) =
∑m
g=1 φ(x
∗
i1; µ̂
∗
g1, σ̂
2
gA) · · · φ(x
∗
iK ; µ̂
∗
gK , σ̂
2
gA)∑m
g=1 ŵiφ(x
∗
i ; 0, σ̂
2
g0)
. (8)
Analogously to the two-sample method, each gene is mean centered around zero to obtain the
transformed data x∗i . In the 1-sample case, the data do not have to be mean centered because there
is no nuisance location parameter present.
4.6 Existing methods
Most of the existing methods for identifying diﬀerentially expressed genes implicitly make the
Normal distribution assumption that we have made. The statistic for gene i is then formed by
ĝi(xi)/f̂i(xi). When the estimated parameters deﬁning f̂i and ĝi are the maximum likelihood
estimates, then ĝi(xi)/f̂i(xi) is equivalent to employing the usual t-statistic (Lehmann 1986). When
the maximum likelihood estimates are shrunken towards a common value (across genes), then the
so-called SAM statistic and other similar versions emerge (Tusher et al. 2001, Cui et al. 2005,
Efron et al. 2001). Therefore, these more intricate statistics use information across genes only in
that diﬀerent estimates are employed in ĝi(xi)/f̂i(xi). Not surprisingly, these modiﬁed statistics
sometimes perform worse than the traditional t-statistic and F-statistic (Section 5).
4.7 Overall algorithm for identifying diﬀerentially expressed genes
The following is a description of the estimated ODP for identifying diﬀerentially expressed genes.
The basic approach is to form estimated versions of the ODP statistics, and then assess signiﬁcance
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using the q-value (Storey 2002, Storey & Tibshirani 2003). Full details of this algorithm, including
exact formulas can be found in the Supplementary Material. Note that one can also determine
a useful signiﬁcance threshold through estimates of the EFP and ETP, which we also outline in
the Supplementary Material.
Proposed Algorithm for Identifying Diﬀerentially Expressed Genes
1. Using the formula given above in equation (8), evaluate the estimated ODP statistic for each
gene.
2. For B iterations, simulate data from the null distribution for each gene by the bootstrap,
and re-compute each statistic to get a set of null statistics. (Note: The bootstrap sampling
is carried out so that for each iteration, the same resampled arrays are applied to all genes.
This keeps the dependence structure of the genes intact.)
3. Using these observed and null statistics, estimate the q-value for each gene as previously
described (Storey 2002, Storey & Tibshirani 2003).
The algorithm generates an estimated q-value for each gene and a ranking of the genes from
most signiﬁcant to least signiﬁcant. The q-value is like the well-known p-value, but it is designed
for the FDR; the q-value of a gene gives the FDR that is incurred when calling that gene and all
others with larger statistics signiﬁcant (Storey 2003, Storey & Tibshirani 2003). One may call genes
signiﬁcant for diﬀerential expression by forming a q-value cut-oﬀ at an appropriate level (say, 1%,
5%, or 10%), or one may simply report the q-value for every gene and let each individual researcher
choose a level of desirable signiﬁcance. We now apply this method to a well known breast cancer
study, and we compare the ODP approach to several highly used existing approaches.
5 Results
5.1 Analysis of breast cancer tumor tissue
We assessed the performance of the ODP on a well-known study comparing the expression of breast
cancer tumor tissues among individuals who are BRCA1-mutation-positive, BRCA2-mutation-
positive, and “Sporadic” (Hedenfalk et al. 2001). The expression measurements used in the study
consist of 3226 genes on 22 arrays; seven arrays were obtained from the BRCA1 group, eight from
the BRCA2 group, and six from the Sporadic group. One sample was not clearly classiﬁable, so we
eliminated it from the analysis here. Also, as previously described (Storey & Tibshirani 2003),
several genes have aberrantly large expression values within a single group, so we eliminated
14
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those genes from the analysis. Genes were ﬁltered that had any absolute expression measure-
ment greater than 20, which is well beyond several times the interquartile range from the median.
These steps left measurements on 3169 genes from 21 arrays. The raw data were obtained from
http://research.nhgri.nih.gov/microarray/NEJM Supplement/ and all data were analyzed on
the log2 scale. We applied our proposed procedure to identify diﬀerentially expressed genes between
the BRCA1 and BRCA2 groups, and also between all three groups.
We compared our approach to ﬁve leading techniques, including (i) the highly-used SAM soft-
ware based on Tusher et al. (2001) and Storey (2002), (ii) the traditional t-tests and F-tests as
previously suggested for microarray analysis (Kerr et al. 2000, Dudoit et al. 2002), (iii) a recently
proposed variation on these that uses “shrunken” versions of the statistics (Cui et al. 2005), (iv)
a non-parametric Bayesian method whose estimated posterior probabilities are also sometimes
interpreted as estimated Bayesian “local FDR” estimates (Efron et al. 2001), and (v) a model-
based empirical Bayes method giving posterior probabilities of diﬀerential expression (Lonnstedt
& Speed 2002).
The methods were compared to determine how accurately and eﬃciently each one extracts the
relevant biological signal. Each method produces some sort of statistic for each gene, as well as
a rule for thresholding these statistics. We used this information to estimate q-values for each
gene according to previously described methodology (Storey 2002, Storey & Tibshirani 2003). In
order to estimate the q-values, simulated null statistics were calculated for each method. This was
accomplished by simulating the same null data in order to calculate null statistics for each method.
It should be noted that several model based Bayesian methods exist (e.g., Newton et al. 2001,
Townsend & Hartl 2002, Newton et al. 2004) for identifying diﬀerentially expressed genes. In
particular, Newton et al. (2004) oﬀers an interesting semi-parametric empirical Bayes approach
that provides an estimate of a novel Bayesian version of the FDR. The method is not included
in our comparison because of its diﬀerent approach to quantifying the FDR. We have only com-
pared methods that have been proposed in or are easily amenable to the framework of calculating
signiﬁcance based on a resampling-based frequentist FDR.
Newton et al. (2004) and three of the methods we include in our comparison (Tusher et al.
2001, Efron et al. 2001, Lonnstedt & Speed 2002) are able to capture asymmetry in diﬀerential
expression signal for when comparing two groups. Tusher et al. (2001) and Efron et al. (2001) do
not do so for three or more groups, so they are essentially equivalent to a standard F-test for three
or more groups or time course studies. As we have described, the ODP captures any structure
in the signal; this could be asymmetry in diﬀerential expression for two or more groups, variance
structure, or structured temporal trajectories in a time course study.
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Figure 2: A comparison of the ODP approach to ﬁve leading methods for identifying diﬀerentially expressed genes
(described in the text). The number of genes found to be signiﬁcant by each method over a range of estimated
q-value cut-oﬀs is shown. The methods involved in the comparison are the proposed ODP (black), SAM (turquoise),
the traditional t-test/F-test (red), a shrunken t-test/F-test (green), a non-parametric empirical Bayes “local FDR”
method (a: blue, b: turquoise), and a model-based empirical Bayes method (fuchsia). (a) Results for identifying
diﬀerential expression between the BRCA1 and BRCA2 groups in the Hedenfalk et al. data. (b) Results for
identifying diﬀerential expression between the BRCA1, BRCA2, and Sporadic groups in the Hedenfalk et al. data.
The model-based empirical Bayes methods have not been detailed for a 3-sample analysis, so they are omitted in this
panel. 16
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5.2 Numerical results on the breast cancer data
The methods were compared by considering the number of genes called signiﬁcant across a range of
FDR cut-oﬀs, which gives an estimate of the relative ETP levels at each given FDR (Supplementary
Material). For the methods employed here, this is equivalent to comparing the ETP for each ﬁxed
EFP level or p-value cut-oﬀ on a slightly diﬀerent scale. Intuitively, the number of genes called
signiﬁcant quantiﬁes the relative amount of biological information obtained at a given noise level.
Figure 2 plots the number of genes called signiﬁcant among the diﬀerent methods across a range
of estimated q-value cut-oﬀs.
In testing for diﬀerential expression between the BRCA1 and BRCA2 groups, the ODP approach
shows surprisingly large improvements in performance over existing methods. For example, at a
FDR level of 3%, our proposed approach ﬁnds 117 signiﬁcant genes, whereas existing methods only
ﬁnd 41–68 signiﬁcant genes. The estimated ODP method therefore oﬀers increases from 72% to
185% in the number of genes called signiﬁcant. The median increase in the number of genes called
signiﬁcant at q-value cut-oﬀs less than or equal to 10% ranges from 43–87% across all methods. In
testing for 3-sample diﬀerential expression among the BRCA1, BRCA2, and Sporadic groups, the
ODP approach oﬀers even greater improvements. For example, it provides increases from 123–217%
in the number of genes called signiﬁcant at a false discovery rate of 3%. Table 1 shows a number
of additional comparisons.
An important point is that it is not surprising that the relative performance of the ODP ap-
proach is even better in the 3-sample case. The existing methods no longer take into account any
asymmetry in the diﬀerential expression signal across genes, as they are mostly exactly equivalent
to or variations on F-statistics. Whereas in the 2-sample setting there are two possible directions
for diﬀerential expression, there are now six directions in the 3-sample setting. The ODP takes ad-
vantage of any systematic asymmetry of diﬀerential expression in both the 2-sample and 3-sample
settings, whereas it is not possible to do so using any version of an F-statistic. If one were to
apply the ODP approach to time course analyses (Storey et al. 2005), then the gains may be even
more substantial because in that setting the asymmetry is even harder to quantify using traditional
statistics.
5.3 Biological signiﬁcance
In order to determine whether the ODP leads to additional biological information, we considered our
ﬁndings relative to those of the ﬁve existing methods in the context of identifying genes diﬀerentially
expressed between the BRCA1 and BRCA2 groups. It is well known that breast tumors associated
with BRCA1 mutations and BRCA2 mutations diﬀer greatly from each other in their histological
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Table 1: Improvements of the ODP approach over existing thresholding methods. Shown are the minimum, median,
and maximum percentage increases in the number of genes called signiﬁcant by the proposed ODP approach relative
to the existing approaches among FDR levels 2%, 3%, . . . , 10%. The exact same FDR methodology (Storey 2002,
Storey & Tibshirani 2003) was applied to each thresholding method in order to make the comparisons fair. The
model-based Bayesian methods (Lonnstedt & Speed 2002) is not deﬁned for a 3-sample analysis, so that case is
omitted.
% Increase by ODP – 2-sample % Increase by ODP – 3-sample
Thresholding Method Minimum Median Maximum Minimum Median Maximum
SAM (Tusher et al. 2001) 29 43 72 76 92 211
t/F-test (Dudoit et al. 2002, Kerr et al. 2000) 52 86 185 63 82 407
Shrunken t/F-test (Cui et al. 2005) 34 52 77 61 69 154
Bayesian “local FDR” (Efron et al. 2001) 58 87 117 76 92 211
Posterior probability (Lonnstedt & Speed 2002) 44 60 113 – – –
appearance (Lakhani et al. 1998). For example, whereas tumors with BRCA1 mutations exhibit
a higher mitotic index and more lymphocytic inﬁltration, tumors with BRCA2 mutations are
heterogeneous, are of a median or high grade, and show a reduced tubule formation (Lakhani
et al. 1998). Concordant with these morphological diﬀerences, the gene expression proﬁles of these
two types of tumors have also shown to be distinctive (Hedenfalk et al. 2001).
At a q-value cut-oﬀ of 5%, we found 232 genes to be diﬀerentially expressed. Many of the
genes that we identiﬁed agree with the morphological changes mentioned above. Thirty-six of
these genes are known to have functions associated with the cell cycle, including many important
molecules such as PCNA, cyclin D1 (CCND1), cyclin-dependent kinase inhibitor 2C (CDKN2C),
CDC20 cell division cycle 20 (CDC20), CDC28 protein kinase regulatory subunit 2 (CKS2), cell
division cycle 25B (CDC25B), and CHK1 checkpoint (CHEK1). The majority of these cell-cycle
genes are up-regulated in BRCA1 positive tumors, except for cyclin D1, whose over-expression in
BRCA2 associated tumors has been shown to be a useful marker for BRCA2 related breast cancer
(Hedenfalk et al. 2001). Closely related to cell cycle and cell proliferation functions, many genes
over-expressed in the BRCA1 group are found to be associated with apoptosis and genome stability:
P53BP2, MSH2, PDCD5, Myc oncogene, and others. Many of these genes have been described in
an earlier analysis of this study (Hedenfalk et al. 2001).
At a q-value cut-oﬀ of 5%, the ﬁve existing methods found between 115–153 genes to be sig-
niﬁcant. Almost every gene identiﬁed by these other methods is among the 232 genes found by
our ODP method. However, we ﬁnd many more genes with the same error rate. Many important
genes would have been missed had we not use the proposed method. Example genes include cell
division cycle 25B (CDC25B), connective tissue growth factor (CTGF), growth factor receptor-
bound protein 2, CCAAT/enhancer binding protein beta (CEBPB), among others. In general, the
gene ranking of the proposed ODP approach appears to be notably diﬀerent than that of the other
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methods. Figure 6 of the Supplementary Material shows the ranking of the top 200 genes from the
proposed ODP approach versus each gene’s ranking from the other ﬁve methods. In the two-sample
comparison, genes ranked in the top 100 by the ODP approach were ranked nearly as low as 600 by
other methods. In the three-sample comparison, genes ranked in the top 200 by the ODP approach
were ranked lower than 400 by other methods.
5.4 Simulation results
Similar comparisons were made on simulated data, where one knows with certainty which genes are
diﬀerentially expressed. Across a range of scenarios, our proposed method continued to perform
favorably over the existing methods. It is certainly possible to ﬁnd some simulation scenario
where the estimated ODP is outperformed, but this should be distinguished from the fact that it
is impossible to outperform the true ODP regardless of which simultaneous-thresholding rule one
employs. Under certain simulation scenarios, the true ODP can be reduced to a simple rule. As an
extreme example, if data are simulated so that every gene has the same variance, and the signal
is symmetric about zero (that is, if one gene is positively diﬀerentially expressed, then there exists
another gene with negative diﬀerential expression of the same magnitude), then it can be shown
that the true ODP reduces to ranking genes by the absolute values of the fold change.
This fact is important to keep in mind when using simulations to evaluate the various procedures.
Most of the existing procedures make speciﬁc assumptions when deriving their statistics; if these
assumptions are enforced in the simulations, then clearly that particular method will be among
the top. One advantage of our proposed method is that it does make fairly general assumptions.
Because of this, it performed well under a range of scenarios.
We show results from four diﬀerent scenarios in Figures 3 and 4 in order to give a ﬂavor of the
relative performance of the various methods. Both ﬁgures are based on the same four simulation
scenarios. In moving from scenario (a) to (d) , increasingly complicated structure is included in
the data. Scenario (a) is based on data with no high-dimensional structure; the true ODP is more
or less equivalent to ranking genes based on absolute fold change. In this scenario, two groups are
compared, there is perfectly symmetric diﬀerential expression and the variances are simulated from
a unimodal, well-behaved distribution.
Scenario (b) has some asymmetry in the diﬀerential expression, but the signals and the variances
are simulated from distributions similar to those motivating the methods in Lonnstedt & Speed
(2002) and Cui et al. (2005). Two groups are compared, there is moderate asymmetry in the
diﬀerential expression, and the variances are simulated from a bimodal distribution. In scenario (c),
three groups are compared, there is slight asymmetry in diﬀerential expression, and the variances
are simulated from a unimodal, well-behaved distribution. Similarly, scenario (d) also compares
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Figure 3: A comparison of the ODP approach to ﬁve leading methods for identifying diﬀerentially expressed genes
(described in the text and Figure 2) based on simulated data. The number of genes found to be signiﬁcant by each
method over a range of estimated q-value cut-oﬀs is shown for a single, representative data set from each scenario.
The proposed ODP approach is in black and the other methods are in grey. In general, the data sets increase in
complexity from panels (a) to (d). (a) In this scenario, two groups are compared, there is perfectly symmetric
diﬀerential expression and the variances are simulated from a unimodal, well-behaved distribution. (b) Two groups
are compared, there is moderate asymmetry in the diﬀerential expression, and the variances are simulated from
a bimodal distribution. (c) Three groups are compared, there is slight asymmetry in diﬀerential expression, and
the variances are simulated from a unimodal, well-behaved distribution. (d) Three groups are compared, there is
moderate asymmetry in diﬀerential expression, and the variances are simulated from a bimodal distribution.
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Figure 4: A comparison of the ODP approach to ﬁve leading methods for identifying diﬀerentially expressed genes
(described in the text and Figure 2) based on simulated data. The expected number of true positive (ETP) genes
is shown for each true FDR level. As opposed to Figure 3, we have averaged over 100 data sets here and taken into
account knowledge of which genes are true and false discoveries in order to make these exact calculations. Panels
(a), (b), (c), and (d) are analogous to those in Figure 3.
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three groups, but there is more asymmetry in diﬀerential expression, and the variances are simulated
from a bimodal distribution.
All data sets were generated using the R statistical software package; the code used to generate
the data can be found in the Supplementary Material. In each scenario, we simulated data from 3000
genes on eight samples from each biological group, where one third of the genes are diﬀerentially
expressed. These commonalities were enforced and the signal to noise structure was made similar
in order to more clearly demonstrate the operating characteristics of our proposed approach and
the relative behavior to existing methods. The fact that one third of the genes are diﬀerentially
expressed does not have a large impact on the relative performance of the various methods. We
merely chose this number to closely match the overall signal in the Hedenfalk et al. (2001) data
and to provide enough signal to make the comparisons clearer.
Figure 3 is based on a single set of data from each scenario, where the number of signiﬁcant
genes is plotted against cut-oﬀ applied to the estimated q-values. The purpose of this ﬁgure is to
show that the relative behavior of the various methods shown in Figure 2 on the Hedenfalk et al.
(2001) data can be recapitulated with simulated data. Figure 4 shows results averaged over 100
data sets each, where we have plotted true FDR versus true ETP for each method. This ﬁgure
compares the relative performance of each method based on knowledge of the true status of each
gene, as opposed to the empirical comparisons of Figures 2 and 3.
There are a number of reasons for the less dramatic improvements one sees in Figure 4 relative
to Figure 3, including the fact that the y-axis is on a diﬀerent scale. A major reason is that Figure
4 does not include the fact that in practice the q-values must be estimated for each method. The
conservativeness of these estimates is greatly aﬀected by the estimate of the proportion of true
nulls (Storey 2002, Storey et al. 2004), which depends on how well the method ranks the least
diﬀerentially expressed genes. Our proposed approach tends to rank the genes better at both ends,
showing the most dramatic improvements when one takes into account both the ranking of the
most signiﬁcant genes and the q-value estimation, which are both necessary in practice.
Finally, we veriﬁed that each method does in fact control the FDR. Figure 7 of the Supplemen-
tary Material shows the estimated q-values based on Storey & Tibshirani (2003) compared to the
true FDR across a relevant range of values. It can be seen that all methods we have considered
here, including our proposed method, conservatively estimate the FDR at all estimated q-value
cut-oﬀs.
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6 Discussion
We have presented a new approach for the signiﬁcance analysis of thousands of features in a
high-dimensional biological study. The approach is based on estimating the optimal procedure for
applying a signiﬁcance threshold to these features, called the optimal discovery procedure (ODP).
We developed a detailed method that can be used to identify diﬀerentially expressed genes in
microarray experiments. This method showed substantial improvements over ﬁve of the leading
approaches that are currently available. This method is available in the open-source, point-and-click
EDGE software package available at http://faculty.washington.edu/jstorey/edge/.
Although the basic theoretical ODP result is straightforward to state (Storey 2005), applying
it in practice requires some care. Speciﬁcally, one must make sure to avoid over-ﬁtting or letting
nuisance parameters have a strong eﬀect on the results. We have proposed some simple guidelines
here to accomplish this, although each speciﬁc application will need to be considered carefully. We
used Normal probability density functions in our microarray method, mainly because the data are
continuous and can be shown to be approximately Normal. If one were to analyze some sort of count
data, such as that obtained when analyzing genome sequences, then an appropriate distribution
such as the Poisson or Binomial can be used instead. Some early investigations indicate that the
ODP approach may also oﬀer substantial improvements for tests involving count data. Note that
the actual signiﬁcance can be calculated nonparametrically, so one does not necessarily have to use
the correct parametric distribution in order to obtain a good procedure.
An important point is that characterizing the true ODP in a particular application can be a
powerful tool for developing an estimated ODP. For example, if every gene’s expression has the
same variance, and the diﬀerential expression signal across genes is perfectly symmetric about zero,
then under the Normal distribution assumption it can be shown that the true ODP is equivalent
to ranking the genes based on the absolute diﬀerence in gene expression (i.e., the simple log-scale
fold-change criterion). Clearly this exact situation would never occur in practice, but it stresses
the fact that the approach proposed here deﬁnes a concrete goal for large-scale signiﬁcance testing:
to estimate the true ODP as well as possible.
In motivating the ODP approach, we described two major steps involved in large-scale signif-
icance testing: ranking the features and assigning a signiﬁcance level to each one. However, for
a number of genomics applications, another step may involve deciding exactly what a “feature”
is. For example, in genome-wide tests of association or in protein mass spectrometry analysis, a
feature may be a window of adjacent observations, or features may even overlap. These are ques-
tions that are also likely to play a major role in developing methods that take full advantage of
the high-dimensional nature of the data. We do not claim that the exact method developed for
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microarrays will serve as an oﬀ-the-shelf procedure to apply to any large-scale signiﬁcance testing
problem. However, we do project that the basic ODP framework and some of the tactics that we
employed can serve as a useful example for how one approaches these high-dimensional signiﬁcance
analyses.
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7 A Simple Motivating Example
The following toy example provides some intuition into the operating characteristics of the ODP in
the context of high-dimensional biological studies. Suppose that an expression study is performed
on 15 individuals, seven of which come from one group and eight from another, where the goal is
to identify genes that are diﬀerentially expressed between these two groups. This design reﬂects
the breast cancer study we consider below. Figure 5 shows a heat map of simulated expression
data over 1000 genes under this study design, where the genes have been hierarchically clustered
(Eisen et al. 1998). It can be seen that there is substantial structure among the diﬀerentially
expressed genes. Most obviously, there is asymmetry in the diﬀerential expression: more genes are
over-expressed in Group 2 than in Group 1. However, among the diﬀerentially expressed genes
there are three distinct patterns. Some of these patterns make it more straightforward to detect
diﬀerential gene expression than others. Moreover, the more genes with a common diﬀerential
expression pattern, the more fruitful it is (in terms of the ETP to EFP trade-oﬀ) to call these
genes diﬀerentially expressed.
The ODP takes this kind of structure into account, and uses it to optimally extract the diﬀeren-
tial expression signal from the noise. The distinct patterns of diﬀerential expression are denoted in
Figure 5. The genes present in each cluster will have similar likelihood functions. Moreover, some
types of likelihood functions will be more distinct from the null likelihoods than others. The ODP
considers the data for each gene and evaluates it at the true likelihoods, forming a ratio of the sum
of the data evaluated at the true alternative likelihoods to that of the true null likelihoods. The
precision to which the structure can be captured depends on the level of complexity of the model
for the data deﬁning the likelihood functions.
Note that this type of structure will be present in other high-dimensional biological studies.
For example, in population-based genetic tests of association, contiguous SNPs will show similar
genotypic patterns. Therefore, regions showing true associations with a trait of interest will do so
in a similar manner.
8 Detailed algorithm for identifying diﬀerentially expressed genes
The following is a detailed description of the full algorithm for identifying diﬀerentially expressed
genes that was presented in the main text.
Let xij be the expression observation for gene i in array j, for i = 1, . . . ,m and j = 1, . . . , n.
The data for a single gene is written as xi = (xi1, xi2, . . . , xin). Assume there are K groups tested
for diﬀerential expression, and let xik be the subset of data from group k, k = 1, . . . ,K. Finally,
let Gk be the set of arrays corresponding to group k so that xik = (xij)j∈Gk . Gene i in group k has
2
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Figure 5: Simulated expression data showing structure in the biological signal of interest. A heat map of expression
data on 1000 genes among 15 individuals is shown (red = high, blue = low). The ﬁrst seven individuals come from
Group 1 and the last eight from Group 2. The genes were hierarchically clustered, and it can be seen that four distinct
clusters of genes emerge: (A) No diﬀerential expression; (B) Moderate over-expression in Group 2, low variance; (C)
Strong over-expression in Group 2, large variance; (D) Strong over-expression in Group 1, large variance. Further,
there is pervasive asymmetry in diﬀerential expression towards Group 2. The proposed ODP approach captures this
structure and uses it to optimally separate signal from noise in identifying diﬀerentially expressed genes.
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mean gene expression µik, and variance σ
2
i . Without loss of generality, we deﬁne the mean when
the null hypothesis of no diﬀerential expression is true to be µi0 =
∑K
k=1 nkµik/n, where nk is the
number of arrays in group k.
Step 1: Calculating ODP statistics. Let (µ̂i0, σ̂
2
i0) be estimates under the constraints of the
null hypothesis, and (µ̂i1, . . . , µ̂iK , σ̂
2
i1) be unconstrained estimates. These are deﬁned as follows:
µ̂i0 =
n∑
j=1
xij/n; σ̂
2
i0 =
n∑
j=1
(xij − µ̂i0)
2
n− 1
µ̂ik =
∑
j∈Gk
xij/nk; σ̂
2
iA =
K∑
k=1
∑
j∈Gk
(xij − µ̂ik)
2
n−K
Note that these are the typical estimates for Normally distributed data. The estimated weights ŵi
for inclusion of each null density in the denominator of the statistic are calculated as detailed in
the main text.
When K = 1 and diﬀerential expression is deﬁned to be average expression not equal to zero
(which would be the case when examining the log ratios of expression from a direct comparison
using two-channel microarrays), the estimated ODP statistic for gene i (i = 1, . . . ,m) is
ŜODP(xi) =
∑m
g=1 φ(xi; µ̂g1, σ̂
2
gA)∑m
g=1 ŵiφ(xi; 0, σ̂
2
g0)
.
When K > 1 each gene is centered as a step in approximately achieving “nuisance parameter
invariance” as described in the main text. Deﬁne x∗ij = xij − µ̂i0 and µ̂
∗
ik = µ̂ik − µ̂i0. The
estimated ODP statistic for each gene i is then
ŜODP(xi) =
∑m
g=1 φ(x
∗
i1; µ̂
∗
g1, σ̂
2
gA) · · · φ(x
∗
iK ; µ̂
∗
gK , σ̂
2
gA)∑m
g=1 ŵiφ(x
∗
i ; 0, σ̂
2
g0)
.
Centering each gene induces a slight dependence among the x∗ij within a gene, but this can be taken
into account by modifying the deﬁnition of the Normal densities φ. However, this turns out to be
algebraically proportional to the original deﬁnition, so no modiﬁcation is actually necessary. Note
that by centering each gene, we lose no information about diﬀerential expression.
Step 2: Simulating null statistics. We obtain null statistics by applying the standard boot-
strap procedure for generating the null distribution when testing the location parameter(s) of a
distribution (Efron & Tibshirani 1993). Let i be the alternative model residuals obtained from
each gene i’s expression data xi by setting ij = xij − µ̂ik(j) where k(j) is the group to which array
j belongs for i = 1, . . . ,m. For each gene i, a bootstrap null set of data for gene i, x0i , is obtained
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by resampling n observations with replacement from among the ij and adding these back to the
estimated null mean µ̂i0. For B iterations, bootstrap from the null distribution the expression
data and re-compute each statistic to get a set of null statistics ŜODP(x
0b
i ) for b = 1, . . . , B and
i = 1, . . . ,m. Each bootstrap sampling is applied to all genes, keeping the dependence structure of
the genes intact.
It should be noted that the standard permutation null scheme (see, for example, that carried
out in Storey & Tibshirani 2003) could be applied here as well. However, the ODP statistic does
not carry the same pivotality properties as, say, a t-statistic. Therefore, the null permuted data
from a gene with a strong diﬀerential expression signal can produce null data with a much larger
variance than its true null. If many genes have a strong signal, then the null statistics from these
genes are not representative of the true null distributions. Since the bootstrap null removes the
signal from each gene before resampling, we have found the bootstrap approach to be more reliable
in this setting. It appears more research into this issue is warranted.
Step 3: Estimating q-values. According to the ODP approach, each possible signiﬁcance cut-oﬀ
is formed by calling all genes signiﬁcant with ŜODP(xi) ≥ c for some cut-point c. The algorithm
for estimating q-values presented in Storey (2002) and Storey & Tibshirani (2003) is written in
terms of p-values. We show here that if p-values are calculated for each gene in a certain fashion,
then one can employ the existing p-value based q-value estimation so that direct thresholding of
the statistics actually takes place. This avoids the need to re-develop q-value estimation and the
theory justifying it, while allowing us to form ODP statistic thresholds (i.e., ŜODP(xi) ≥ c) rather
than p-value based thresholds.
Suppose that the p-value for gene i is calculated by
pi =
∑B
b=1
∑m
j=1 1
(
ŜODP(x
0b
j ) ≥ ŜODP(xi)
)
m · B
, (10)
where 1(·) is standard indicator function equal to one when the argument is true and zero other-
wise. When p-values are calculated in this pooled, gene non-speciﬁc way, the subsequent q-value
estimation procedure as deﬁned in Storey (2002) is equivalent to estimating q-values by directly
thresholding the statistics. The following estimate of the false discovery rate when calling all p-
values ≤ t signiﬁcant is implicit in the algorithm for estimating q-values (Storey 2002, Storey &
Tibshirani 2003):
F̂DR(t) =
π̂0m · t∑m
i=1 1 (pi ≤ t)
.
For a ﬁxed signiﬁcance cut-oﬀ c applied to the original statistics, the analogous false discovery
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rate estimate is
F̂DR(c) =
π̂0
∑B
b=1
∑m
i=1 1
(
ŜODP(x
0b
i ) ≥ c
)
/B∑m
i=1 1
(
ŜODP(xi) ≥ c
) , (11)
where π̂0 is derived from a smoother ﬁt to the
π̂0(c
′) =
∑m
i=1 1
(
ŜODP(xi) < c
′
)
∑B
b=1
∑m
i=1 1
(
ŜODP(x
0b
i ) < c
′
)
/B
over some range of c′ exactly as in the algorithm given in Storey & Tibshirani (2003).
As was stated in Storey & Tibshirani (2003), the original FDR estimate of Storey (2002) is
easily shown to be equivalent to the above formula when p-values are calculated as above. The
key observation is that one can equivalently deﬁne the Type I error rate of a given cut-oﬀ by∑B
b=1 #{ŜODP(x
0b
i ) ≥ c}/(m · B) rather than the p-value threshold t. In fact, if we deﬁne
c(t) ≡ min{ŜODP(xi) : pi ≤ t}
then it can be shown that
π̂0
∑B
b=1
∑m
i=1 1
(
ŜODP(x
0b
i ) ≥ c(t)
)
/B∑m
i=1 1
(
ŜODP(xi) ≥ c(t)
) = π̂0m · t∑m
i=1 1 (pi ≤ t)
making the two false discovery rate estimates equal. Therefore, q-values derived from either method
are equal as long as the p-values are calculated from the gene non-speciﬁc empirical distribution of
the simulated null statistics.
Out of these derivations come direct estimates for the EFP and ETP for each ODP threshold.
In particular, for a threshold c deﬁne
ÊFP(c) =
π̂0
∑B
b=1
∑m
i=1 1
(
ŜODP(x
0b
i ) ≥ c
)
B
ÊTP(c) =
m∑
i=1
1
(
ŜODP(xi) ≥ c
)
− ÊFP(c)
where π̂0 is estimated as above. The FDR estimate from equation (11) can then be written in terms
of these estimates, further showing the direct connection between the EFP, ETP, and FDR:
F̂DR(c) =
ÊFP(c)
ÊFP(c) + ÊTP(c)
. (12)
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We estimate q-values for our ODP approach in a new way. We pool simulated null statistics
across genes as above, but we do not employ the null statistics from every gene. Speciﬁcally, we
only use null statistics from genes with ŵi = 1, i.e., those represented in the denominator of the
statistic. We have found this produces more well behaved estimates of the q-values over using null
statistics from every gene. In implementing this approach, the above formulas are simply replaced
with the proper subset of null statistics. For a ﬁxed signiﬁcance cut-oﬀ c applied to the original
statistics, the EFP and ETP estimates are:
ÊFP(c) =
π̂0
∑B
b=1
∑m
i=1 ŵi1
(
ŜODP(x
0b
i ) ≥ c
)
B
∑m
i=1 ŵi/m
,
ÊTP(c) =
m∑
i=1
1
(
ŜODP(xi) ≥ c
)
− ÊFP(c).
The estimates π̂0(c
′) are analogously modiﬁed to
π̂0(c
′) =
∑m
i=1 1
(
ŜODP(xi) < c
′
)
P
B
b=1
P
m
i=1
bwi1( bSODP(x0bi )<c′)
B
P
m
i=1
bwi/m
.
The overall estimate π̂0 is formed by smoothing over some range of c
′ exactly as in the above
algorithm. We then plug these estimates into equation (12) in order to estimate FDR for a given
threshold c. Finally, the q-value estimate for each gene i is:
q̂i = min
c≤ bSODP(xi)
F̂DR(c),
i.e., the minimum estimated FDR among all thresholds where gene i is called signiﬁcant.
9 Comparing procedures based on the number of genes called
signiﬁcant
The ODP approach was compared to ﬁve leading procedure for identifying diﬀerentially expressed
genes by comparing the number of genes called signiﬁcant at each FDR level. It is straightforward
to show that this is an empirical version of the comparison based on the ETP for each ﬁxed FDR.
This follows since ÊTP = (# signiﬁcant genes)(1− F̂DR), as just shown above. Since each method
is compared at the same value of F̂DR, it follows that comparing the number of signiﬁcant genes
is equivalent to comparing the methods based on ÊTP, which we showed above provides a valid
estimate of the true ETP. Note that it can also be shown based on these arguments that this
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comparison gives equivalent information about relative performance based on comparing ÊTP for
each ﬁxed ÊFP level.
10 Nuisance parameter invariance
The ODP is most simply deﬁned in terms of the following rule (Storey 2005):
gm0+1(x) + gm0+2(x) + · · ·+ gm(x)
f1(x) + f2(x) + · · ·+ fm0(x)
.
If each hypothesis test has identically deﬁned null and alternative hypotheses then diﬀerences
between the fi would be due to nuisance parameters. For example, consider the 2-sample microarray
problem where the null hypothesis for each test is that µi1 = µi2 and the alternative is µi1 = µi2.
Above, we deﬁned µi0 = (n1µi1 + n2µi2)/n, which is the common mean when the null hypothesis
is true. Under the Normal distribution assumption, the ODP rule is based on∑m
i=m0+1
φ(x;µi1, µi2, σ
2
i )∑m0
i=1 φ(x;µi0, σ
2
i )
, (13)
where as before tests 1, 2, . . . ,m0 have true null hypotheses and the remainder have true alternative
hypotheses. Diﬀerences between the null densities φ(x;µi0, σ
2
i ) are due to diﬀering µi0 and σ
2
i , which
are not used at all in deﬁning the null and alternative hypotheses. The parameters µi0 and σ
2
i are
therefore nuisance parameters.
In the Neyman-Pearson setting, nuisance parameters are usually “canceled out” in some fash-
ion, making them irrelevant in the hypothesis tests. In practice, “pivotal statistics” are desirable
because their null distributions do not depend on any unknown nuisance parameters. In the sin-
gle signiﬁcance test setting, nuisance parameters are most troublesome in that they make it more
diﬃcult to calculate a null distribution. In the ODP setting, the presence of nuisance parameters
is troublesome for another reason: since the ODP is deﬁned in terms of the true likelihood of each
test, one can manipulate the ODP quite substantially by varying the degree by which the nuisance
parameters values diﬀer between the true null and true alternative tests.
Speciﬁcally, consider the above statistic in equation (13) under the scenario where µ10 = · · · =
µm0,0 = −1000 and µm0+1,0 = · · · = µm0 = 1000, as opposed to the scenario where µ10 = · · · =
µm0 = 0. Clearly these two scenarios would yield very diﬀerent results. In the former case, it
would be much easier to distinguish the true null hypotheses from the true alternative hypotheses.
However, in practice it is not clear how much this matters since in the former case, one would not
be able to estimate the ODP nearly as well. Similar examples can be constructed in terms of the
8
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nuisance parameters σ2i . We have also found that certain types of nuisance parameter eﬀects can
lead to over-ﬁtting of the data in the signiﬁcance testing (see below). Therefore, it is desirable from
a variety of perspectives to eliminate these eﬀects as much as possible.
In the context of this Normal distribution example, one way to avoid eﬀects from nuisance
parameters is to transform the data so that the null distributions are all equal to the N(0, 1)
distribution. This can be done by replacing xij with (xij − µi0)/σi. In practice, this could be
accomplished instead with estimated values, (xij − µ̂i0)/σ̂i. The null distribution of every gene
would then approximately be N(0, 1). This is obviously an extreme form of what we call “nuisance
parameter invariance” because all nuisance parameters have been removed from the data. In our
experience, this particular choice does not work well because there is relevant information in the
σ2i , and dividing the data by σ̂i induces a lot of extra noise into the expression measurements.
A weaker criterion for nuisance parameter invariance involves a type of subset exchangeability
across null distributions. In particular, we require that the average null likelihood among all tests is
equal to that from the true null tests:
∑m
i=1 fi/m =
∑m0
i=1 fi/m0. This implies that the likelihoods
of the true nulls cannot be pathologically diﬀerent from the true alternatives simply because of
nuisance parameter values. In the Normal example, one may approximately achieve this property
by forcing all µi0 = 0 (leading to no loss of information or addition of noise) and removing any
relationship between the signal µi1 − µi2 and the variances σ
2
i .
Let x∗ be the mean centered data for a single gene (thereby removing the eﬀect of µi0), and let
µ∗i1 = µi1−µi0, µ
∗
i2 = µi2−µi0, µ
∗
i0 = 0. In the case that
∑m
i=1 φ(·; 0, σ
2
i )/m =
∑m0
i=1 φ(·; 0, σ
2
i )/m0,
the following statistics are all equivalent:∑m
i=m0+1
φ(x∗;µ∗i1, µ
∗
i2, σ
2
i )∑m0
i=1 φ(x
∗; 0, σ2i )
∑m
i=m0+1
φ(x∗;µ∗i1, µ
∗
i2, σ
2
i )∑m
i=m0+1
φ(x∗; 0, σ2i )∑m
i=m0+1
φ(x∗;µ∗i1, µ
∗
i2, σ
2
i )∑m
i=1 φ(x
∗; 0, σ2i )
∑m0
i=1 φ(x
∗; 0, σ2i ) +
∑m
i=m0+1
φ(x∗;µ∗i1, µ
∗
i2, σ
2
i )∑m
i=1 φ(x
∗; 0, σ2i )
The fact that the two on the top row are equivalent is reassuring in that the true null and true
alternative hypotheses do not diﬀer in their average likelihoods due to nuisance parameters. The
bottom two statistics show the transition from the original ODP (top left) to the straightforwardly
estimated ODP (bottom right), which was used to motivate our proposed microarray method.
In order to approximately obtain the condition
∑m
i=1 φ(·; 0, σ
2
i )/m =
∑m0
i=1 φ(·; 0, σ
2
i )/m0, ﬁrst
mean center the data for each test. Then perform a proper transformation so that there is no
apparent relationship between the diﬀerence in average expression between the two groups and the
sample variances. This latter step has been well-studied in general and in the context of microarrays
(Rocke & Durbin 2003).
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11 Over-ﬁtting
In a single test procedure, the null statistic is calculated under the assumption that the data come
from the null distribution. When the statistic involves estimation of parameters, the estimation is
carried out with null data when calculating null statistics. For example, suppose that a generalized
likelihood ratio statistic, ĝ(x)/f̂ (x), is formed, and a resampling based p-value is to be calculated.
This involves randomly resampling the data under the null distribution to obtain null data x0b for
b = 1, . . . , B iterations. The null statistics are calculated by ĝ0b(x0b)/f̂0b(x0b) where ĝ0b and f̂0b
are the new estimates based on x0b.
In our proposed procedure the null statistics are calculated by ŜODP(x
0b
i ), where ŜODP is the es-
timated thresholding function based on the original data. In other words, we do not re-estimate the
densites using the null data. When calculating the null distributions of many tests, the assumption
is that some subset of m0 null hypotheses are true and the remaining m−m0 are false. Therefore,
the correct null distribution would be calculated by (i) resampling the m0 true nulls from their
null distributions, (ii) resampling the remaining m −m0 from their alternative distributions, (iii)
re-estimating ŜODP, and (iv) calculating the EFP based on the null statistics calculated among the
m0 true nulls.
Since we cannot identify the m0 true nulls, we resample all data from their null distributions
and we use the originally estimated thresholding function. We do not re-estimate ŜODP for each set
of resampled data because these data are all null, and we want to be able to control the error rate
under the case where m0 are true nulls and m−m0 are true alternatives. Re-estimating ŜODP for
each set of full null data would result in a gross inﬂation of signiﬁcance.
The danger in calculating the null statistics as we have done is that over-ﬁtting could cause
some artiﬁcial inﬂation of signiﬁcance. If our procedure were carried out for a single test, then this
inﬂation would be very noticeable. However, we were not able to detect any evidence of over-ﬁtting
for our proposed procedure in a variety of scenarios. For example, we randomly selected 1000 genes
from the Hedenfalk et al. data set and randomly permuted their data (within genes) so that we
could be certain that these 1000 were true nulls. We then performed our procedure, calculating p-
values for every gene exactly as described in our algorithm. The p-values corresponding to the 1000
known null genes were then tested for equality to the Uniform distribution through a Kolmogorov-
Smirnov test. According to the Kolmogorov-Smirnov test carried out over many iterations of this
simulation, the p-values followed the Uniform distribution nearly perfectly1.
There seem to be two reasons why our procedure does not suﬀer from over-ﬁtting. The ﬁrst is
1That is, for each iteration of this simulation, a Kolmogorov-Smirnov p-value was calculated, and then these were
again tested against the Uniform distribution, indicating that there was no evidence among the many simulations
that the ODP p-values deviated from a Uniform distribution.
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that the ODP thresholding function is estimated from thousands of genes, so the variance of this
estimate is negligible. In other words, one can randomly select a subset of, say, 1500 genes, estimate
the ODP by these, and apply it to all of the data. The results will be virtually identical to using
the entire data set. This is evidence that as the number of genes grows large, the estimated ODP
eventually settles down to some ﬁxed form. The second reason why we are able to avoid over-ﬁtting
is based on the approximate nuisance parameter invariance that was achieved. Because of this, the
signals of true alternatives were not allowed to aﬀect the overall sum of null densities.
Regardless, an extra precaution one can take is the following. When calculating resampling
based null statistics for gene i, replace ĝi and f̂i with versions estimated from the resampled null data
for gene i. The over-ﬁtting of gene i is most likely to occur in ĝi and f̂i, so these can be re-estimated
while not disturbing the status of the other signiﬁcance tests. If a gene’s data are very diﬀerent than
all the other genes, then this adjustment is crucial because the other estimated densities contribute
negligible amounts to its statistic, making this gene’s statistic especially susceptible to over-ﬁtting.
If this extra precaution is taken then we do not foresee over-ﬁtting to be an issue in typical data
sets. One can also always test for over-ﬁtting in the manner that we did with the Hedenfalk et al.
study.
12 Simulation Details
The following displays the R code used to generate each data set from the four simulation scenarios
considered in detail here. In each scenario, we simulated data from 3000 genes on eight samples
from each biological group, where one third of the genes are diﬀerentially expressed. These com-
monalities were enforced and the signal to noise structure was made similar in order to more clearly
demonstrate the operating characteristics of our proposed approach and the relative behavior to
existing methods.
Scenario a:
dat <- matrix(rnorm(3000*16), ncol=16)
y <- c(rep(1,8),rep(2,8))
sigma2 <- 0.5 + rgamma(1500, shape=2, rate=4)
sigma2 <- c(sigma2, runif(1500, min=1.7, max=2.2))
sigma2 <- sample(sigma2)
mu <- rep(0,3000)
mu[1:200] <- rnorm(200, mean=1, sd=0.3)
mu[201:333] <- 1.2
mu[334:800] <- rnorm(467, mean=-1.0, sd=0.3)
mu[801:1000] <- -0.9
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mu[1:1000] <- abs(mu[1:1000])*sample(c(rep(1,500),rep(-1,500)))
for(i in 1:3000) {
dat[i,1:8] <- dat[i,1:8]*sqrt(sigma2[i])
dat[i,9:16] <- dat[i,9:16]*sqrt(sigma2[i]) + rep(mu[i],8)
}
Scenario b:
dat <- matrix(rnorm(3000*16), ncol=16)
y <- c(rep(1,8),rep(2,8))
sigma2 <- runif(1000, min=0.5, max=0.75)
sigma2 <- c(sigma2, runif(500, min=1.2, max=1.3))
sigma2 <- c(sigma2, runif(1500, min=1.7, max=2.2))
sigma2 <- sample(sigma2)
mu <- rep(0,3000)
mu[1:200] <- rnorm(200, mean=1, sd=0.3)
mu[201:333] <- -1.2
mu[334:800] <- rnorm(467, mean=-1.0, sd=0.3)
mu[801:1000] <- -0.9
for(i in 1:3000) {
dat[i,1:8] <- dat[i,1:8]*sqrt(sigma2[i])
dat[i,9:16] <- dat[i,9:16]*sqrt(sigma2[i]) + rep(mu[i],8)
}
Scenario c:
dat <- matrix(rnorm(3000*24), ncol=24)
y <- c(rep(1,8),rep(2,8),rep(3,8))
sigma2 <- runif(3000, min=0.5, max=1.25)
sigma2 <- sample(sigma2)
mu <- rep(0,3000)
mu[1:200] <- rnorm(200, mean=1, sd=0.3)
mu[201:333] <- -1.2
mu[334:800] <- rnorm(467, mean=-1.0, sd=0.3)
mu[801:1000] <- -0.9
mu[1:1000] <- abs(sample(mu[1:1000]))
for(i in 1:600) {
dat[i,y==1] <- dat[i,y==1]*sqrt(sigma2[i])
dat[i,y==2] <- dat[i,y==2]*sqrt(sigma2[i]) + rep(mu[i],8)
dat[i,y==3] <- dat[i,y==3]*sqrt(sigma2[i])
}
for(i in 601:1000) {
dat[i,y==1] <- dat[i,y==1]*sqrt(sigma2[i])
dat[i,y==2] <- dat[i,y==2]*sqrt(sigma2[i])
dat[i,y==3] <- dat[i,y==3]*sqrt(sigma2[i]) + rep(mu[i],8)
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}for(i in 1001:3000) {
dat[i,] <- dat[i,]*sqrt(sigma2[i])
}
Scenario d:
dat <- matrix(rnorm(3000*24), ncol=24)
y <- c(rep(1,8),rep(2,8),rep(3,8))
sigma2 <- runif(1000, min=0.5, max=0.75)
sigma2 <- c(sigma2, runif(500, min=1.2, max=1.3))
sigma2 <- c(sigma2, runif(1500, min=1.7, max=2.2))
sigma2 <- sample(sigma2)
mu <- rep(0,3000)
mu[1:200] <- rnorm(200, mean=1, sd=0.3)
mu[201:333] <- -1.2
mu[334:800] <- rnorm(467, mean=-1.0, sd=0.3)
mu[801:1000] <- -0.9
mu[1:1000] <- abs(sample(mu[1:1000]))
for(i in 1:700) {
dat[i,y==1] <- dat[i,y==1]*sqrt(sigma2[i])
dat[i,y==2] <- dat[i,y==2]*sqrt(sigma2[i]) + rep(mu[i],8)
dat[i,y==3] <- dat[i,y==3]*sqrt(sigma2[i])
}
for(i in 701:1000) {
dat[i,y==1] <- dat[i,y==1]*sqrt(sigma2[i])
dat[i,y==2] <- dat[i,y==2]*sqrt(sigma2[i])
dat[i,y==3] <- dat[i,y==3]*sqrt(sigma2[i]) + rep(mu[i],8)
}
for(i in 1001:3000) {
dat[i,] <- dat[i,]*sqrt(sigma2[i]) }
13
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Figure 6: The gene ranking of the ODP versus the existing ﬁve methods when identifying diﬀerentially expressed
genes from the Hedenfalk et al. data. For each of the top 200 ranked genes according to the ODP approach (x-axis),
the ranking given by the other methods is plotted (y-axis). It can be seen that the ODP approach yields a notably
diﬀerent ranking of the genes. The identity line is shown in red, indicating whether the other methods produce a
ranking higher or lower than the ODP approach. (a) Two-sample analysis identifying diﬀerentially expressed genes
between BRCA1 and BRCA2 mutation positive tumors. (b) Three-sample analysis identifying diﬀerentially expressed
genes between BRCA1, BRCA2, and Sporadic tumors.
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Figure 7: Plots verifying that each method considered controls the FDR by using the estimated q-value methodology
of Storey (2002) and Storey & Tibshirani (2003). For each of the four simulation scenarios considered (a–d; see main
text and Section 13 above), the estimated q-values versus the true FDR are plotted. The proposed ODP method is
plotted in black, the other methods are plotted in grey, and the dotted line is the identity function. It can be seen
that the estimated q-values conservatively estimate the FDR in all cases.
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